LFM
ABBV icon

LGT Fund Management’s AbbVie ABBV Stock Holding History

LGT Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
49,911
+1,580
+3% +$340K 0.52% 36
2026
Q1 		$10.5M Buy
48,331
+38,356
+385% +$8.51M 0.46% 48
2025
Q4 		$2.29M Sell
9,975
-1,579
-14% -$360K 0.18% 124
2025
Q3 		$2.82M Buy
11,554
+1,186
+11% +$242K 0.23% 106
2025
Q2 		$1.92M Sell
10,368
-4,586
-31% -$852K 0.17% 132
2025
Q1 		$3.13M Sell
14,954
-6,285
-30% -$1.22M 0.28% 76
2024
Q4 		$3.77M Buy
21,239
+17,188
+424% +$3.16M 0.33% 67
2024
Q3 		$797K Buy
4,051
+1,467
+57% +$274K 0.08% 137
2024
Q2 		$443K Buy
+2,584
New +$428K 0.06% 149

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LGT Fund Management's ABBV Position: Q2 2026 in Review

LGT Fund Management increased its AbbVie (ABBV) stake by 3.3% in Q2 2026, buying an estimated $340K and bringing the position to 49,911 shares worth $12.6M. The position accounts for 0.52% of the portfolio, ranked #36.

LGT Fund Management first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LGT Fund Management held 49,911 shares of AbbVie worth $12.6M as of Q2 2026.
  • LGT Fund Management bought 1,580 AbbVie shares in Q2 2026, an estimated $340K.
  • AbbVie made up 0.52% of LGT Fund Management's portfolio in Q2 2026, its #36 holding.
  • LGT Fund Management first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.